Aisling Capital Partners III LLC, 10% Owner, Director at Loxo Oncology, Inc. (LOXO), bought 232,558 shares at $21.50 ($5.0M) on 2016-05-17, disclosed to the SEC on 2016-05-19.
Open-market purchase of $5.0M LOXO by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| TTOO | BUY | 2015-12-09 | $3.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |
| LOXO | BUY | 2015-11-16 | $2.2M | — | Filing → |